+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Glucose Testing Market - Global Forecast 2026-2032- Product Image
Blood Glucose Testing Market - Global Forecast 2026-2032- Product Image
Sale

Blood Glucose Testing Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5094051
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Glucose Testing Market is projected to reach USD 25.81 Billion in 2026. It is expected to continue growing at a CAGR of 10.73%, reaching USD 47.76 Billion by 2032.

Blood glucose testing has become a core pillar of diabetes diagnosis, therapy optimization, and long-term complication prevention. The market spans self-monitoring blood glucose meters, test strips, lancets, continuous glucose monitoring systems, hospital point-of-care analyzers, and connected digital platforms that support clinical decisions across home, retail, laboratory, and acute-care settings.

Demand is anchored by the global diabetes burden. The International Diabetes Federation estimated that 589 million adults were living with diabetes in 2024, with prevalence expected to rise materially by 2050. This expanding patient population, together with wider insulin use, gestational diabetes screening, aging demographics, and the shift toward value-based care, is sustaining the need for accurate, accessible, and interoperable blood glucose testing solutions.

Transformative Shifts in the Blood Glucose Testing Landscape

The blood glucose testing landscape is shifting from episodic fingerstick measurement toward continuous, connected, and patient-centered monitoring. Continuous glucose monitoring is gaining adoption because it provides trend data, time-in-range metrics, and alerts that single-point testing cannot deliver, while traditional blood glucose meters remain essential for affordability, confirmation testing, hospital workflows, and markets with constrained reimbursement.

Regulatory expectations and clinical guidelines are also raising the performance bar. Accuracy standards such as ISO 15197 and national device requirements continue to influence product design, while healthcare systems increasingly prioritize remote monitoring, digital therapeutics integration, and data sharing among patients, clinicians, caregivers, and payers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the value of blood glucose testing from measurement to prediction, personalization, and workflow automation. AI-enabled analytics can identify glycemic patterns, support hypoglycemia risk alerts, improve insulin titration recommendations, and help clinicians prioritize patients who need intervention, particularly when combined with continuous glucose monitoring, electronic health records, and connected insulin delivery systems.

The cumulative impact is strongest where algorithms are validated, explainable, and integrated into regulated clinical pathways. Industry leaders must balance innovation with cybersecurity, data privacy, bias monitoring, and clinical evidence generation, because glucose data can directly influence medication decisions and patient safety.

Key Regional Insights

Asia-Pacific is one of the most important growth engines for blood glucose testing due to large diabetes populations in China, India, Japan, South Korea, and Australia, alongside rising diagnosis rates and expanding private healthcare access. The region combines high-volume demand for affordable meters and strips with accelerating uptake of connected glucose monitoring in urban and insured populations.

North America remains a high-value market supported by advanced reimbursement structures, strong adoption of continuous glucose monitoring, and a mature ecosystem of endocrinology practices, pharmacies, and digital health platforms. Europe benefits from structured diabetes care pathways, national health systems, and regulatory harmonization, while Latin America shows steady demand as Brazil and Mexico scale access to diabetes screening and chronic disease management.

The Middle East is advancing through government-led diabetes prevention strategies, high per-capita healthcare spending in several Gulf states, and hospital modernization. Africa presents a long-term access opportunity, where affordability, primary-care diagnostics, supply reliability, and diabetes education are critical to improving glucose testing penetration and supporting earlier disease management.

Key Group Insights

ASEAN markets are characterized by rising urbanization, growing type 2 diabetes prevalence, and a need for cost-effective blood glucose testing that can serve both primary care and home monitoring. The GCC is differentiated by high diabetes prevalence, strong public health investment, and rapid adoption of hospital-based and connected diabetes technologies.

The European Union supports market consistency through medical device regulation, procurement standards, and established chronic care systems, while BRICS countries represent scale-driven demand across large populations with varied reimbursement and infrastructure maturity. G7 markets continue to lead in premium device adoption, evidence-based reimbursement, and digital integration, whereas NATO member countries collectively reflect strong hospital procurement capacity, coordinated healthcare infrastructure, and growing emphasis on medical supply resilience.

Key Country Insights

The United States is the most commercially mature country for advanced blood glucose testing, supported by broad continuous glucose monitoring adoption, pharmacy distribution, remote patient monitoring, and payer coverage for eligible populations. Canada benefits from provincial reimbursement pathways and strong clinical guideline adoption, while Mexico and Brazil show rising demand tied to expanding diabetes diagnosis, urban healthcare access, and private-sector participation.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain structured diabetes management programs, with Germany and France particularly important for reimbursement-led technology adoption. Russia remains a sizable market where domestic distribution, procurement policies, and economic constraints shape device availability.

China and India represent the largest volume opportunities due to their diabetes populations, with affordability and distribution breadth central to market success. Japan, Australia, and South Korea are advanced markets with strong healthcare infrastructure, high technology acceptance, and growing use of connected monitoring solutions across home care and specialist diabetes management.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated accuracy, affordability, and seamless data interoperability. Portfolio strategies should include both low-cost self-monitoring solutions for high-volume markets and premium continuous glucose monitoring platforms for patients who benefit from trend-based decision support.

Organizations should expand partnerships with payers, pharmacies, telehealth providers, and diabetes clinics to improve adherence and recurring utilization. Investment in patient education, multilingual applications, supply-chain redundancy, cybersecurity, and real-world evidence will strengthen market access and support sustainable differentiation.

Research Methodology

This executive summary is based on secondary research from recognized public health agencies, regulatory frameworks, clinical guidelines, reimbursement policies, and peer-reviewed evidence on diabetes monitoring. Key reference points include global diabetes prevalence estimates, device accuracy standards, healthcare utilization patterns, and adoption trends for self-monitoring and continuous glucose monitoring.

Findings were synthesized using triangulation across disease burden, technology adoption, reimbursement maturity, regional healthcare infrastructure, and clinical positioning. The methodology emphasizes verified, data-backed insights and avoids speculative projections that cannot be supported by credible industry or public health evidence.

Conclusion

Blood glucose testing is moving from a device-led category to a connected diabetes management ecosystem. Accurate meters and strips remain indispensable, while continuous glucose monitoring and AI-enabled analytics are redefining how patients, clinicians, and payers interpret glycemic control.

The strongest opportunities will belong to organizations that combine regulatory-grade performance, accessible pricing, digital integration, and evidence-based outcomes. As diabetes prevalence continues to rise worldwide, blood glucose testing will remain central to preventive care, treatment optimization, and chronic disease management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Glucose Testing Market, by Product Type
7.1. Introduction
7.2. Blood Glucose Meters
7.3. Control Solutions
7.4. Lancets
7.5. Sensors
7.5.1. Continuous Glucose Monitoring Sensors
7.5.2. Flash Glucose Monitoring Sensors
7.6. Test Strips
8. Blood Glucose Testing Market, by Technology
8.1. Introduction
8.2. Electrochemical Sensors
8.3. Optical Techniques
8.4. Thermal Techniques
9. Blood Glucose Testing Market, by Modality
9.1. Introduction
9.2. Point-of-Care Testing (POCT)
9.2.1. Hospital Bedside Testing
9.2.2. Clinic-Based Testing
9.3. Home Care Testing
9.3.1. Personal Glucose Monitoring Devices
9.3.2. Wearable CGM Devices
9.4. Laboratory-Based Testing
9.4.1. Fasting Plasma Glucose (FPG)
9.4.2. Oral Glucose Tolerance Test (OGTT)
9.4.3. HbA1c Testing
10. Blood Glucose Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Home Care
10.4. Hospitals And Clinics
11. Blood Glucose Testing Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Blood Glucose Testing Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Blood Glucose Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Blood Glucose Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 77 Elektronika Kft.
16.2. Abbott Laboratories
16.3. ACON Laboratories, Inc
16.4. AgaMatrix, Inc.
16.5. ARKRAY, Inc.
16.6. Ascensia Diabetes Care Holdings AG
16.7. B. Braun Medical Ltd.
16.8. Becton Dickinson and Company
16.9. Beurer Belgium
16.10. Dexcom, Inc.
16.11. ForaCare Suisse AG
16.12. i-SENS, Inc.
16.13. Johnson & Johnson
16.14. LifeScan IP Holdings, LLC
16.15. Medisana AG
16.16. Medtronic PLC
16.17. Merck KGaA
16.18. Microlife AG
16.19. Neogen Corporation
16.20. Nipro Corporation
16.21. Nova Biomedical
16.22. Omron Healthcare, Inc.
16.23. Roche Diagnostics Nederland BV
16.24. Rossmax International Ltd.
16.25. Sanofi S.A.
16.26. Sinocare Inc.
16.27. Terumo Corporation
16.28. Trividia Health, Inc.
16.29. VivaChek Laboratories Inc.
List of Figures
FIGURE 1. GLOBAL BLOOD GLUCOSE TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BLOOD GLUCOSE TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BLOOD GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CONTROL SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CONTROL SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CONTROL SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL LANCETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL LANCETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL LANCETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL FLASH GLUCOSE MONITORING SENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FLASH GLUCOSE MONITORING SENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL FLASH GLUCOSE MONITORING SENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ELECTROCHEMICAL SENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ELECTROCHEMICAL SENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ELECTROCHEMICAL SENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL OPTICAL TECHNIQUES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL OPTICAL TECHNIQUES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL OPTICAL TECHNIQUES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL THERMAL TECHNIQUES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL THERMAL TECHNIQUES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL THERMAL TECHNIQUES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL POINT-OF-CARE TESTING (POCT) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL POINT-OF-CARE TESTING (POCT) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL POINT-OF-CARE TESTING (POCT) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HOSPITAL BEDSIDE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HOSPITAL BEDSIDE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL HOSPITAL BEDSIDE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL HOME CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL HOME CARE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL HOME CARE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PERSONAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PERSONAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PERSONAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL WEARABLE CGM DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL WEARABLE CGM DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL WEARABLE CGM DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL FASTING PLASMA GLUCOSE (FPG) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL FASTING PLASMA GLUCOSE (FPG) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL FASTING PLASMA GLUCOSE (FPG) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ORAL GLUCOSE TOLERANCE TEST (OGTT) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ORAL GLUCOSE TOLERANCE TEST (OGTT) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ORAL GLUCOSE TOLERANCE TEST (OGTT) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HBA1C TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HBA1C TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HBA1C TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 114. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 116. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 117. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 118. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 119. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 120. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 121. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 122. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 134. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 136. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 137. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 138. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 139. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 140. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 141. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 142. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 147. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 148. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 150. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 151. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 152. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 153. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 155. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 157. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 158. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 159. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 160. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 161. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 162. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 163. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 175. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 176. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 178. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 180. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 181. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 182. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 183. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 185. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 186. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 187. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 188. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 189. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 190. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 191. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 192. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 193. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 194. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 195. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 196. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 197. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 198. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 199. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 200. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 201. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 202. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 203. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 209. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 211. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 212. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 213. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 215. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 216. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 217. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 218. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 219. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 220. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 221. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 222. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 223. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 224. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 226. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 227. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 228. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 229. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 230. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 231. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 232. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 233. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 234. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 236. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 238. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 239. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 241. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 242. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 243. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 244. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 247. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 249. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 250. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 251. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 252. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 253. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 256. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 259. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 260. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 261. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 262. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 263. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 264. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 266. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 267. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 268. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 269. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 271. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 272. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 273. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 274. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 276. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 277. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 278. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 279. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 280. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 281. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 282. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 286. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 288. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 289. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 291. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 292. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 293. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 294. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 296. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 297. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 298. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 299. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 300. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 301. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 302. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 303. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 304. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 307. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 308. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 309. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 310. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 311. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 312. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 313. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 314. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 315. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 316. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 317. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 318. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 319. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 320. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 321. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 322. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 323. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 324. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 326. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 328. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 329. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 330. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 331. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 332. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 333. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 334. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 336. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 337. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 338. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 339. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 340. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2017-2032 (USD MILLION)
TABLE 341. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2017-2032 (USD MILLION)
TABLE 342. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2017-2032 (USD MILLION)
TABLE 343. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2017-2032 (USD MILLION)
TABLE 344. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 346. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 347. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 348. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2017-2032 (USD MILLION)
TABLE 349. SOUTH KOREA BLOOD GLUCOSE

Companies Mentioned

  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Medical Ltd.
  • Becton Dickinson and Company
  • Beurer Belgium
  • Dexcom, Inc.
  • ForaCare Suisse AG
  • i-SENS, Inc.
  • Johnson & Johnson
  • LifeScan IP Holdings, LLC
  • Medisana AG
  • Medtronic PLC
  • Merck KGaA
  • Microlife AG
  • Neogen Corporation
  • Nipro Corporation
  • Nova Biomedical
  • Omron Healthcare, Inc.
  • Roche Diagnostics Nederland BV
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • VivaChek Laboratories Inc.

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 25.81 Billion
Forecasted Market Value ( USD ) by 2032 $ 47.76 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Blood Glucose Monitoring Market - Global Forecast 2026-2032 - Product Image

Blood Glucose Monitoring Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Blood Glucose Lancets Market - Global Forecast 2026-2032 - Product Image

Blood Glucose Lancets Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Blood Glucose Monitoring Systems - Global Strategic Business Report - Product Image

Blood Glucose Monitoring Systems - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Blood Glucose Test Strips - Global Strategic Business Report - Product Image

Blood Glucose Test Strips - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report by Product, Connectivity, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report by Product, Connectivity, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.